Position in INCY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$821,860
+$296,765 QoQ
Shares Held
7,250
+30.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#442
of 849 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Banco Santander, S.A. holds $93,187,790 across 6 Biotechnology names. INCY ranks #4 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
108,075 | $53,684,094 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51,479 | $32,099,214 | |
| 3 | MRNA |
Moderna, Inc.
|
86,677 | $6,069,989 | |
| 4 | INCY |
Incyte Corp
This page
|
7,250 | $821,860 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
3,582 | $292,183 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
13,029 | $220,450 |
All Filings in INCY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $821,860 | 7,250 | Shares | Defined | 2026-07-29 | |
| 2026-03-31 | $525,095 | 5,579 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $551,037 | 5,579 | Shares | Defined | 2026-02-13 | |
| 2024-09-30 | $6,241,029 | 94,418 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $7,191,714 | 118,636 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $6,758,692 | 118,636 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $8,684,170 | 138,305 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $7,989,879 | 138,305 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $6,696,170 | 107,569 | Shares | Defined | 2023-08-14 | |
| 2020-03-31 | $247,224 | 3,376 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||